patient no & affected eye |
age, sex |
IOP at NVG (IOP before NVG) ※1 |
OH or POAG ※2 |
NVE & NVD※ 3 |
Period between NVG and PRP ※4 |
IOP of 6 months after accomplishment of PRP, ※5 |
1 R |
44, M |
40 (12, 12) |
- |
II→II, +→+ |
14 m |
28, + |
2 R |
59, M |
34 (16, 16) |
- |
I→0, +→+ |
20 m |
25, + |
3 R |
61, F |
27 (18) |
- |
I→0, - |
15 m |
20, + |
L |
|
26 (18) |
- |
I→0, - |
18 m |
20, + |
4 R |
60, M |
22 (16, 16) |
- |
II→0, - |
3 m |
18, + |
5 L |
43, M |
39 (10,10) |
- |
II→I, +→- |
4 m |
17, + |
6 R |
68, M |
42 (23, 28) |
+ (0.8, 1.0) |
II→I, - |
3 m |
26, +, TLE ※6 |
7 R |
65, F |
28 (14) |
- |
II→0, - |
4 m |
18, + |
L |
|
28 (14) |
- |
II→0, +→- |
4 m |
20, + |
8 R |
52, M |
25 (11) |
- |
II→I, - |
3 m |
18, + |
L |
|
26 (13) |
- |
II→0, - |
3 m |
18, + |
9 L |
56, F |
36 (/) ※2 |
- |
I→I, +→- |
2 m |
18, + |
10 L |
55, M |
54 (/) ※2 |
- |
II→I, +→+ |
2 m |
26, +, TLE ※6 |
11 L |
62, M |
50 (18, 18) |
- |
I→I, +→- |
4 m |
30, +, TLE ※6 |
12 R |
69, M |
30 (16,15) |
- |
I→0, - |
4 m |
26, +, TLE ※6 |
13 L |
71, F |
38 (24,23) |
+(0.2, 0,2) |
0→0, +→+ |
4 m |
27, + |
14 L |
60, M |
27 (18,18) |
+(0.8, 0.7) |
I→0, - |
3 m |
23, + |
15 L |
71, M |
27 (17,18) |
- |
I→0, - |
3 m |
25, +, TLE ※6 |
16 L |
42, M |
23 (10, 10) |
- |
I→0, +→- |
4 m |
16, + |
NVD: optic disc neovascularization, NVG: neovascular glaucoma, PRP: pan-retinal photocoagulation, TLE: trabeculectomy
※ 1: Values in ( ) indicate IOP before the occurrence of neovascular glaucoma (NVG). Values in (,) indicate IOP of R & L eyes before the occurrence of NVG.
※ 2: Existence of ocular hypertension (OH) or primary open angle glaucoma (POAG) before the occurrence of neovascular glaucoma. () indicate cup/disc ratio
in the right and left eyes before the occurrence of NVG. IOPs in Patients 6, 13 and 14 indicate under the topical glaucoma medication.
※ 3: 3: Neovascularization elsewhere (NVE) and optic disc neovascularization (NVD) before and after accomplishment of pan-retinal photocoagulation Number
of NVE: 0=0, I=1-3, II=4>
※ 4: Period between the diagnosis of neovascular glaucoma and achievement of PRP.
※ 5: +- indicates with or without topical anti-glaucoma medication.
※ 6: Trabeculectomy was performed within six months after achieving PRP |